Is steroid therapy needed in IPF or not?

A. Merzi Ozturk, N. Demir Firat, D. Karnak, O. Kayacan (Ankara, Turkey)

Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Session: A wide spectrum of idiopathic pulmonary fibrosis
Session type: Thematic Poster Session
Number: 684
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Merzi Ozturk, N. Demir Firat, D. Karnak, O. Kayacan (Ankara, Turkey). Is steroid therapy needed in IPF or not?. Eur Respir J 2009; 34: Suppl. 53, 684

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mild asthma. Is constant therapy by inhaled steroids necessary?
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006

Is antibiotic treatment during asthma exacerbation necessary ?
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017


How are we going to treat IPF patients in the future?
Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges
Year: 2013


What influences patient choice of antifibrotic treatment in IPF?
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020


Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021


How often do asthma patients claim prescribed therapy?
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017


Does combination therapy lead to better adherence in asthma?
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010


Suppression of FENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019
Year: 2019



Is there a benefit of an additive standard immunoglobulin therapy for the clinical course of COPD patients under chronic immunosuppressive therapy?
Source: Eur Respir J 2001; 18: Suppl. 33, 24s
Year: 2001

Does inhaled corticosteroid use affect the risk of ?COVID-19-related death?
Source: Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020
Year: 2021



Investigating the steroids and long-acting β2-agonists combination: why do we need more?
Source: Eur Respir J 2004; 23: 501-502
Year: 2004


Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020


What do patients with COPD need to know?
Source: Eur Respir J 2003; 22: Suppl. 45, 168s
Year: 2003

Inhaled immunotherapy for lung cancer? Certainly possible.
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018

New treatment of IPF still unknown?
Source: ERS Live 2007
Year: 2007


Which therapeutic options when CPAP fails? 
Source: ERS Course 2017 - Paediatric noninvasive ventilation
Year: 2017

Mild OSAS: Is CPAP therapy actually required for these patients?
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018